Arcadia Biosciences (FRA:17D) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:17D Arcadia Biosciences Inc FRA:17D
43 GF Score
Price €3.72
GF Value €15.09
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:17D vs ORISF, ARRT, CIMG: Short Percentage of Float Comparison

For the Packaged Foods subindustry, Arcadia Biosciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arcadia Biosciences Short Percentage of Float vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Short Percentage of Float falls into.


FRA:17D
43GF Score
Arcadia Biosciences Inc FRA:17D
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arcadia Biosciences (FRA:17D) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of €3.72 is trading 75.3% below its estimated GF Value™ of €15.09.

Key valuation signals for FRA:17D:

  • Short Percentage of Float:
  • GF Value™: €15.09 vs. price of €3.72 (75.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:17D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcadia Biosciences Business Description

Other Exchanges RKDA:USA
Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for FRA:17D

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€15.09
GF Value